Nuveen Asset Management, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 4 filers reported holding FATE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$608,334
-55.7%
286,950
-0.6%
0.00%
Q2 2023$1,374,312
+109145.8%
288,721
+30.9%
0.00%
Q1 2023$1,258
-58.1%
220,577
-25.9%
0.00%
-100.0%
Q4 2022$3,001
-99.9%
297,483
+14.4%
0.00%
-50.0%
Q3 2022$5,825,000
-45.6%
259,950
-39.9%
0.00%
-50.0%
Q2 2022$10,711,000
-42.6%
432,250
-12.7%
0.00%
-33.3%
Q1 2022$18,668,000
-30.3%
495,044
+8.1%
0.01%
-25.0%
Q4 2021$26,800,000
-5.1%
458,048
-3.8%
0.01%
-11.1%
Q3 2021$28,226,000
-30.6%
476,231
+1.6%
0.01%
-25.0%
Q2 2021$40,694,000
+7.5%
468,864
+2.1%
0.01%0.0%
Q1 2021$37,847,000
-10.4%
459,025
-1.2%
0.01%
-14.3%
Q4 2020$42,260,000
+111.7%
464,754
-7.0%
0.01%
+75.0%
Q3 2020$19,966,000
+9.6%
499,523
-5.9%
0.01%
+14.3%
Q2 2020$18,218,000
+111.0%
530,980
+36.6%
0.01%
+75.0%
Q1 2020$8,635,000
+28.9%
388,773
+13.5%
0.00%
+33.3%
Q4 2019$6,700,000
+37.3%
342,405
+9.0%
0.00%
+50.0%
Q3 2019$4,879,000
-19.7%
314,152
+4.9%
0.00%0.0%
Q2 2019$6,079,000
+475.1%
299,413
+397.7%
0.00%
-66.7%
Q1 2019$1,057,000
+5.6%
60,160
-22.9%
0.01%0.0%
Q4 2018$1,001,000
-34.5%
77,999
-16.9%
0.01%
-25.0%
Q3 2018$1,529,000
+62.0%
93,887
+12.8%
0.01%
+33.3%
Q2 2018$944,000
+78.8%
83,268
+54.0%
0.01%
+100.0%
Q1 2018$528,00054,0630.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders